FdaApplication
BLA 761049
Identifiers
- fda_app_no: BLA761049
Properties
| Property | Value |
|---|---|
| applicant_name | EMD Serono, Inc. |
| application_type | BLA |
| approval_date | 2017-03-23 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BAVENCIO | AVELUMAB | 200MG/10ML (20MG/ML) | Injection |
1 product